Moreover, CYP3A5 has been suggested to serve as a tumor suppressor since lower CYP3A5 levels were associated with a more aggressive disease characterized by vascular invasion, poor differentiation, and shorter RFS and OS in HCC patients [288]. Here, CYP3A5 is linked to hepatocellular carcinoma.